|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/14 | |||
| A61K 9/48 |
| (11) | Number of the document | 2925304 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13859441.1 |
| Date of filing the European patent application | 2013-11-27 | |
| (97) | Date of publication of the European application | 2015-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/072249 |
| Date | 2013-11-27 |
| (87) | Number | WO 2014/085599 |
| Date | 2014-06-05 |
| (30) | Number | Date | Country code |
| 201261731901 P | 2012-11-30 | US |
| (72) |
BRZECZKO, Albert, W., US
HOLLENBECK, R., Gary, US
|
| (73) |
Acura Pharmaceuticals, Inc.,
616 N. North Court, Palatine, IL 60067,
US
|
| (54) | SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT |
| SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT |